INDICATIONS
Periostat® (doxycycline hyclate) is indicated for use as an adjunct to scaling and root planing
to promote attachment level gain and to reduce pocket depth in patients with
adult periodontitis.
DOSAGE AND ADMINISTRATION
THE DOSAGE OF PERIOSTAT® (doxycycline hyclate) DIFFERS FROM THAT OF DOXYCYCLINE USED TO TREAT
INFECTIONS. EXCEEDING THE RECOMMENDED DOSAGE MAY RESULT IN AN INCREASED INCIDENCE
OF SIDE EFFECTS INCLUDING THE DEVELOPMENT OF RESISTANT MICROORGANISMS.
Periostat® (doxycycline hyclate) 20 mg twice daily as an adjunct following scaling and root planing
may be administered for up to 9 months. Periostat® (doxycycline hyclate) should be taken twice
daily at 12 hour intervals, usually in the morning and evening. It is recommended
that if Periostat® (doxycycline hyclate) is taken close to meal times, allow at least one hour
prior to or two hours after meals. Safety beyond 12 months and efficacy beyond
9 months have not been established.
Administration of adequate amounts of fluid along with the tablets is recommended
to wash down the drug and reduce the risk of esophageal irritation and ulceration.
(See ADVERSE REACTIONS Section).
HOW SUPPLIED
Periostat® (doxycycline hyclate) (white tablet imprinted with a PS20) containing
doxycycline hyclate equivalent to 20 mg doxycycline. Bottle of 60 (NDC
64682-008-01), Bottle of 100 (NDC 64682-008-02) and Bottle of 1000 (NDC
64682-008-03).
Storage: All products are to be stored at controlled room temperatures
of 15°C - 30°C (59°F - 86°F) and dispensed in tight, light-resistant
containers (USP).
Manufactured by: Pharmaceutical Manufacturing Research Services,
Inc., Horsham, PA 19044. Marketed by: CollaGenex Pharmaceuticals, Inc., Newtown,
PA, 18940. FDA revision date: 3/31/2004